Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» colon cancer
colon cancer
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Seeking Alpha
Sun, 07/15/12 - 12:25 pm
Fusilev
Spectrum Pharmaceuticals
colorectal cancer
colon cancer
FDA OKs screening test for colon cancer drug
Yahoo/AP
Sat, 07/7/12 - 11:52 am
Qiagen
Erbitux
colon cancer
ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)
The Street
Sun, 06/3/12 - 12:40 pm
colon cancer
Roche
Keryx
perifosine
Avastin
US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor
Pharmabiz
Sat, 05/19/12 - 12:26 pm
Ambit Biosciences
Teva Pharmaceuticals
CEP-32496
cancer
melanoma
lung cancer
thyroid cancer
colon cancer
ovarian cancer
Myriad Study to Benefit Colaris
Yahoo/Zacks.com
Wed, 04/4/12 - 11:22 pm
Colaris
Myriad Genetics
colon cancer
Keryx: Lessons From a Drug Failure
TheStreet.com
Mon, 04/2/12 - 07:22 pm
Keryx
Aeterna Zentaris
colon cancer
perifosine
Keryx: Perifosine Colon Cancer Trial Fails
TheStreet.com
Mon, 04/2/12 - 10:44 am
perifosine
colon cancer
Keryx
Aeterna Zentaris
Look to Exact Sciences, Not Radient Pharma, for Best Colon Cancer Screen Test
TheStreet.com
Mon, 01/23/12 - 02:14 pm
Radient Pharmaceuticals
colon cancer
EXACT Sciences
Onko-Sure
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects
TheStreet.com
Wed, 01/18/12 - 10:01 am
ONYX Pharmaceuticals
colon cancer
Bayer
regorafenib
What to Look For From Keryx and Aeterna Zentaris in 2012
Motley Fool
Thu, 12/29/11 - 10:32 pm
Keryx
Aeterna Zentaris
colon cancer
perifosine
Spectrum's Fusilev Sales Will Suffer As Leucovorin Shortage Is Eliminated
Seeking Alpha
Mon, 12/12/11 - 10:45 am
Spectrum
Fusilev
leucovorin
colon cancer
Spectrum's Fusilev Sales Will Suffer As Leucovorin Shortage Is Eliminated
Seeking Alpha
Sun, 12/11/11 - 02:44 pm
Spectrum Pharmaceuticals
Fusilev
leucovorin
colon cancer
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Bloomberg
Sat, 12/10/11 - 12:38 pm
Fusilev
Spectrum Pharmaceuticals
generics
colon cancer
Why Perifosine Phase 3 Trials Will Likely Fail
Seeking Alpha
Thu, 12/8/11 - 11:26 am
perifosine
Keryx
Aeterna Zentaris
colon cancer
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
TheStreet.com
Sat, 10/29/11 - 12:50 pm
Spectrum Pharmaceuticals
Fusilev
colon cancer
Bayer and new partner Onyx crow over PhIII regorafenib success
Fierce Biotech
Wed, 10/26/11 - 10:30 am
regorafenib
ONYX Pharmaceuticals
Bayer
colon cancer
Keryx CEO: Selling Company 'Top Priority'
TheStreet.com
Thu, 09/8/11 - 11:14 am
Keryx
M&A
colon cancer
perifosine
Bone drug tied to lower colon cancer risk
Yahoo/Reuters
Tue, 08/23/11 - 08:26 am
colon cancer
biophosphonates
Merck
Fosamax
Roche
Boniva
Novartis
Reclast
Actonel
Warner Chilcott
Exact Sciences' Colon Cancer Screening Trial
TheStreet.com
Tue, 07/12/11 - 12:07 pm
colon cancer
EXACT Sciences
Cologuard
Spectrum's Fusilev Supply Edge Easing
TheStreet.com
Tue, 06/21/11 - 11:04 am
Fusilev
Spectrum Pharmaceuticals
leucovorin
colon cancer
Teva Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »